Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX

Kim, J; Ji, E; Jung, K; Jung, IH; Park, J; Lee, JC; Kim, JW; Hwang, JH; Kim, J

Kim, J (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam 13620, South Korea.

JOURNAL OF PERSONALIZED MEDICINE, 2021; 11 (2):

Abstract

Background: The combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is a very effective chemotherapeutic regimen for u......

Full Text Link